Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New findings in the area of breast cancer detailed
June 23rd, 2005
Data on breast cancer are outlined in reports from the United States, France and United Kingdom. Study 1: According to a study from the United States, "Hormone-responsive breast cancer is usually determined by the presence of estrogen receptors (ER) or progesterone receptors (PR) on primary invasive breast cancers. "Adjuvant and metastatic hormone therapy are recommended based on primary ER and PR determination. Little information is available to determine if primary hormone receptors correlate with metastatic disease and if survival is influenced by metastatic receptor status," wrote E.E. Lower and colleagues, University of Cincinnati. ...
Source: Women's Health Weekly (2005-06-23)
|
